Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Withdrawn before enrolling

Conditions studied: BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Breast Carcinoma

In brief

This research study is looking at breast cancer risk in women who are BRCA1/BRCA2 mutation carriers. Studying samples of DNA in the laboratory from women who are BRCA1/BRCA2 mutation carriers may help doctors identify biomarkers related to cancer.

Key facts

Study ID

NCT00899145

Run by

Gynecologic Oncology Group

People needed

0

Starts

2008-05-01

Last updated by the study team

2017-07-13

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with or without a personal history of breast cancer prior to enrollment in Gynecologic Oncology Group (GOG)-0199
• Known currently to be BRCA1/2 mutation carrier either by confirmed outside report or by research testing
• No BRCA1/2 mutation-negative or mutation-unknown status
• Enrolled on clinical trial GOG-0199 AND meets the following criteria:
• Completed baseline questionnaire (BQ-199)
• Provided information on previous breast cancer history, including date of diagnosis
• Provided complete data from the DNA analysis on the genetic variants of interest
• Available DNA samples for analysis
• Hormone receptor status not specified
• Pre- or post-menopausal status

Where it is running

• Gynecologic Oncology Group — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.